Impact of Reported Donor Ejection Fraction on Outcome after Heart Transplantation

Yukiharu Sugimura1, Moritz Benjamin Immohr1, Hug Aubin1

  • 1Department of Cardiac Surgery, University Hospital, Duesseldorf, Germany.

Insights

Using marginal donor hearts with impaired left ventricular function (LVF) in heart transplantation leads to longer hospital stays and more infections, but does not affect survival up to one year.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Organ Donation

Background:

  • The global shortage of donor organs necessitates the use of marginal donor hearts, including those with impaired left ventricular function (LVF).
  • Orthotopic heart transplantation (oHTX) outcomes are influenced by donor heart quality.

Purpose of the Study:

  • To evaluate the clinical outcomes of heart transplant recipients based on donor left ventricular ejection fraction (dLVEF).
  • To determine if impaired donor LVF impacts post-transplant survival and morbidity.

Main Methods:

  • Retrospective analysis of oHTX patients from September 2010 to June 2020.
  • Patients were categorized into two groups: impaired dLVEF (≤50%) and normal dLVEF (>50%).
  • Clinical data, including survival, hospital stay duration, and postoperative infections, were compared between groups.

Main Results:

  • No significant differences in 30-day, 90-day, or 1-year survival were observed between groups.
  • Patients receiving hearts from donors with impaired dLVEF had a statistically longer in-hospital stay (p < 0.05).
  • Postoperative infection events were significantly more frequent in the impaired dLVEF group (p = 0.03), independent of other factors.

Conclusions:

  • Impaired donor LVF is associated with prolonged post-transplant recovery and increased morbidity.
  • Despite increased complications, impaired donor LVF does not significantly impact patient survival up to one year post-transplant.
  • Donor and recipient LVEF are statistically independent parameters.
Abstract